Baxter Other Non-Current Liabilities 2010-2024 | BAX

Baxter other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Baxter other non-current liabilities for the quarter ending September 30, 2024 were $1.263B, a 28.97% decline year-over-year.
  • Baxter other non-current liabilities for 2023 were $1.737B, a 6.01% decline from 2022.
  • Baxter other non-current liabilities for 2022 were $1.848B, a 25.87% decline from 2021.
  • Baxter other non-current liabilities for 2021 were $2.493B, a 49.01% increase from 2020.
Baxter Annual Other Non-Current Liabilities
(Millions of US $)
2023 $1,737
2022 $1,848
2021 $2,493
2020 $1,673
2019 $1,732
2018 $1,559
2017 $1,665
2016 $1,743
2015 $2,425
2014 $4,614
2013 $3,364
2012 $3,073
2011 $2,639
2010 $2,289
2009 $2,030
Baxter Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $1,263
2024-06-30 $1,598
2024-03-31 $1,652
2023-12-31 $1,400
2023-09-30 $1,778
2023-06-30 $1,622
2023-03-31 $1,854
2022-12-31 $1,848
2022-09-30 $2,071
2022-06-30 $2,264
2022-03-31 $2,434
2021-12-31 $2,493
2021-09-30 $1,621
2021-06-30 $1,624
2021-03-31 $1,636
2020-12-31 $1,673
2020-09-30 $1,824
2020-06-30 $1,882
2020-03-31 $1,827
2019-12-31 $1,732
2019-09-30 $1,514
2019-06-30 $1,464
2019-03-31 $1,483
2018-12-31 $1,559
2018-09-30 $1,545
2018-06-30 $1,585
2018-03-31 $1,605
2017-12-31 $1,665
2017-09-30 $1,925
2017-06-30 $1,786
2017-03-31 $1,762
2016-12-31 $1,743
2016-09-30 $1,691
2016-06-30 $1,655
2016-03-31 $2,439
2015-12-31 $2,425
2015-09-30 $2,555
2015-06-30 $3,628
2015-03-31 $3,819
2014-12-31 $4,614
2014-09-30 $3,394
2014-06-30 $3,619
2014-03-31 $3,406
2013-12-31 $3,364
2013-09-30 $3,856
2013-06-30 $3,296
2013-03-31 $3,382
2012-12-31 $3,073
2012-09-30 $2,563
2012-06-30 $2,532
2012-03-31 $2,552
2011-12-31 $2,639
2011-09-30 $2,041
2011-06-30 $2,088
2011-03-31 $2,202
2010-12-31 $2,289
2010-09-30 $2,241
2010-06-30 $2,149
2010-03-31 $2,167
2009-12-31 $2,030
2009-09-30 $2,039
2009-06-30 $1,981
2009-03-31 $1,998
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.062B $14.813B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $198.127B 25.27
Stryker (SYK) United States $138.991B 31.32
Boston Scientific (BSX) United States $131.097B 37.69
EssilorLuxottica (ESLOY) France $109.895B 0.00
Medtronic (MDT) Ireland $103.904B 15.43
Haleon (HLN) United Kingdom $43.864B 28.50
Lonza Group Ag (LZAGY) Switzerland $42.859B 0.00
GE HealthCare Technologies (GEHC) United States $36.052B 18.70
ResMed (RMD) United States $34.830B 28.62
Terumo (TRUMY) Japan $28.875B 0.00
Koninklijke Philips (PHG) Netherlands $23.602B 18.07
Zimmer Biomet Holdings (ZBH) United States $21.325B 13.58
Insulet (PODD) United States $18.698B 74.46
Smith & Nephew SNATS (SNN) United Kingdom $10.781B 0.00
BellRing Brands (BRBR) United States $9.800B 39.43
Bio-Rad Laboratories (BIO) United States $9.168B 31.16
Demant (WILYY) Denmark $7.926B 0.00
Lantheus Holdings (LNTH) United States $6.208B 14.42
Prestige Consumer Healthcare (PBH) United States $3.889B 19.34
ICU Medical (ICUI) United States $3.840B 36.56
Haemonetics (HAE) United States $3.789B 18.49
Perrigo (PRGO) Ireland $3.513B 10.34
Envista Holdings (NVST) United States $3.218B 23.97
QuidelOrtho (QDEL) United States $3.016B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.864B 18.36
Neogen (NEOG) United States $2.609B 30.10
LeMaitre Vascular (LMAT) United States $2.071B 50.34
Green Thumb Industries (GTBIF) United States $1.678B 29.37
AtriCure (ATRC) United States $1.498B 0.00
InMode (INMD) Israel $1.434B 8.63
AdaptHealth (AHCO) United States $1.383B 9.88
Maravai LifeSciences Holdings (MRVI) United States $1.356B 0.00
BioLife Solutions (BLFS) United States $1.271B 0.00
Curaleaf Holdings (CURLF) Canada $0.968B 0.00
Owens & Minor (OMI) United States $0.965B 7.54
CeriBell (CBLL) United States $0.964B 0.00
Phibro Animal Health (PAHC) United States $0.879B 15.49
Evolus (EOLS) United States $0.690B 0.00
Omeros (OMER) United States $0.597B 0.00
Capricor Therapeutics (CAPR) United States $0.594B 0.00
VAREX IMAGING (VREX) United States $0.584B 25.75
Surmodics (SRDX) United States $0.568B 0.00
Verano Holdings (VRNOF) United States $0.452B 0.00
Cresco Labs (CRLBF) United States $0.439B 0.00
Quanterix (QTRX) United States $0.403B 0.00
ZimVie (ZIMV) United States $0.375B 31.63
Biote (BTMD) United States $0.331B 7.26
Valneva SE (VALN) France $0.324B 0.00
Viemed Healthcare (VMD) United States $0.311B 29.56
Canopy Growth (CGC) Canada $0.308B 0.00
Sanara MedTech (SMTI) United States $0.294B 0.00
Cerus (CERS) United States $0.293B 0.00
OraSure Technologies (OSUR) United States $0.272B 18.20
Zynex (ZYXI) United States $0.263B 55.00
High Tide (HITI) Canada $0.242B 100.33
Aurora Cannabis (ACB) Canada $0.234B 0.00
Utah Medical Products (UTMD) United States $0.207B 14.29
Sanuwave Health (SNWV) United States $0.201B 2.82
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.197B 0.00
TerrAscend (TSNDF) Canada $0.190B 0.00
Brainsway (BWAY) Israel $0.174B 92.40
FitLife Brands (FTLF) United States $0.145B 18.17
Jin Medical (ZJYL) China $0.133B 0.00
TriSalus Life Sciences (TLSI) United States $0.124B 0.00
Quipt Home Medical (QIPT) United States $0.107B 0.00
Fonar (FONR) United States $0.096B 10.81
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Veru (VERU) United States $0.095B 0.00
Exagen (XGN) United States $0.091B 0.00
InterCure (INCR) Israel $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.006B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.74
SNDL (SNDL) Canada $0.000B 0.00